An observational study to evaluate the long-term outcomes of treatment with etanercept in patients with plaque-type psoriasis.

Luger, T; Schopf, R E; Schwanke, A; Langhammer, S; Meng, T; Löschmann, P A

Luger, T; Schopf, R E; Schwanke, A; Langhammer, S; Meng, T; Löschmann, P A.

Afiliação

Luger T; Department of Dermatology, University of Munster, Munster, Germany. luger@uni-muenster.de.
Schopf RE; Department of Dermatology, University of Mainz, Mainz, Germany.
Schwanke A; Pfizer Deutschland GmbH, Berlin, Germany.
Langhammer S; Pfizer Deutschland GmbH, Berlin, Germany.
Meng T; Pfizer Deutschland GmbH, Berlin, Germany.
Löschmann PA; Pfizer Deutschland GmbH, Berlin, Germany.

J Eur Acad Dermatol Venereol ; 30(10): 1730-1741, 2016 Oct.

Article em En | MEDLINE | ID: mdl-27297981

Assuntos

Etanercepte/uso terapêutico; Imunossupressores/uso terapêutico; Psoríase/tratamento farmacológico; Adulto; Feminino; Humanos; Masculino; Pessoa de Meia-Idade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Etanercepte / Imunossupressores Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google